Clinical value of cystatin C determination

Michael K. Page, Johannes Bükki, Peter Luppa, Dieter Neumeier

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

It has been reported that cystatin C (cys-C) is elevated in patients with malignant disease. In order to investigate whether this phenomenon is linked to or independent of renal function, and at the same time examine the role of this marker in other pathological situations, cys-C concentrations were compared with 24-h creatinine clearance values in three groups of patients; the first group were undergoing treatment for malignant disease, the second group were renal transplant patients and the third randomly taken from patients for whom a routine creatinine clearance had been requested. Several patients with malignant disease had high cys-C levels without any correspondence to creatinine clearance values. Additionally, although cys-C shows a high sensitivity for detecting impaired glomerular function in renal transplant patients, the specificity was very low, with little discrimination being observed between patients with normal and pathological creatinine clearance levels. In other patients both the sensitivity and specificity of cys-C could be shown to be very good. Thus although cys-C can generally be recommended as a marker of the glomerular filtration rate, there are some patients for whom the clinical relevance is unclear. (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)67-72
Number of pages6
JournalClinica Chimica Acta
Volume297
Issue number1-2
DOIs
StatePublished - Jul 2000

Keywords

  • Creatinine clearance
  • Cystatin C
  • GFR
  • Metastatic disease
  • Renal transplant
  • Specific

Fingerprint

Dive into the research topics of 'Clinical value of cystatin C determination'. Together they form a unique fingerprint.

Cite this